Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.

It was the second drug in its class that had failed for Pfizer. So, David Ricks, Lilly’s CEO, was understandably cautious. It was the latest in a string of milestone moments for the understated ...

It was the second drug in its class that had failed for Pfizer. So, David Ricks, Lilly’s CEO, was understandably cautious. It was the latest in a string of milestone moments for the understated leader ...

Eli Lilly CEO David Ricks speaks during a press conference, on the day of a groundbreaking ceremony to mark the beginning of the construction of the new plant, in Alzey, Germany, April 8 ...

As first quarter earnings begin, executives are confronting market turmoil, regulatory instability and the threat of U.S.

CEO David Ricks said: “We are pleased to see that our latest medicine meets our expectations for safety and tolerability, glucose control and weight loss. “As a convenient once-daily pill ...

Eli Lilly said the pill could be a scalable option for global use, pending regulatory approval. CEO David Ricks noted that the convenience of a daily oral medication may set it apart from injectables ...

could be readily manufactured and launched at scale for use by people around the world,” Lilly CEO David Ricks said in a prepared statement. Currently available GLP-1 drugs are engineered ...

and we look forward to additional data readouts later this year," the company's CEO David Ricks said in a release. Incretin drugs mimic certain gut hormones to suppress a person's appetite and ...